McCarter Private Wealth Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.69M Buy
7,775
+750
+11% +$166K 0.74% 42
2025
Q4
$1.61M Buy
7,025
+1,998
+40% +$455K 0.72% 39
2025
Q3
$1.16M Buy
5,027
+769
+18% +$157K 0.6% 44
2025
Q2
$790K Sell
4,258
-611
-13% -$114K 0.45% 50
2025
Q1
$1.02M Buy
4,869
+51
+1% +$9.91K 0.67% 38
2024
Q4
$856K Sell
4,818
-129
-3% -$23.7K 0.54% 38
2024
Q3
$977K Buy
+4,947
New +$923K 0.62% 39

Other funds holding ABBV

McCarter Private Wealth Services's ABBV Position: Q1 2026 in Review

McCarter Private Wealth Services increased its AbbVie (ABBV) stake by 11% in Q1 2026, buying an estimated $166K and bringing the position to 7,775 shares worth $1.69M. The position accounts for 0.74% of the portfolio, ranked #42.

McCarter Private Wealth Services first reported a position in ABBV in Q3 2024 and has held it in 7 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • McCarter Private Wealth Services held 7,775 shares of AbbVie worth $1.69M as of Q1 2026.
  • McCarter Private Wealth Services bought 750 AbbVie shares in Q1 2026, an estimated $166K.
  • AbbVie made up 0.74% of McCarter Private Wealth Services's portfolio in Q1 2026, its #42 holding.
  • McCarter Private Wealth Services first reported a position in AbbVie in Q3 2024 and has held it in 7 quarters since.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on McCarter Private Wealth Services's 13F filing for Q1 2026, filed 15 May 2026.